vs

Side-by-side financial comparison of KE Holdings Inc. (BEKE) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $3.2B, roughly 1.7× KE Holdings Inc.). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs 3.2%, a 8.4% gap on every dollar of revenue. Over the past eight quarters, KE Holdings Inc.'s revenue compounded faster (9.8% CAGR vs 1.5%).

KE Holdings Inc., operating under the well-known Beike brand, is a leading integrated online and offline residential service platform based in China. It offers a full range of services including second-hand property brokerage, new housing sales agency, home rental, renovation, and related financial consultation to meet diverse housing-related demands of consumers across multiple scenarios.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

BEKE vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.7× larger
THC
$5.5B
$3.2B
BEKE
Higher net margin
THC
THC
8.4% more per $
THC
11.7%
3.2%
BEKE
Faster 2-yr revenue CAGR
BEKE
BEKE
Annualised
BEKE
9.8%
1.5%
THC

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
BEKE
BEKE
THC
THC
Revenue
$3.2B
$5.5B
Net Profit
$104.9M
$644.0M
Gross Margin
21.4%
Operating Margin
2.6%
15.4%
Net Margin
3.2%
11.7%
Revenue YoY
9.0%
Net Profit YoY
12.6%
EPS (diluted)
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BEKE
BEKE
THC
THC
Q4 25
$3.2B
$5.5B
Q3 25
$3.6B
$5.3B
Q2 25
$5.3B
Q1 25
$3.2B
$5.2B
Q4 24
$5.1B
Q3 24
$3.2B
$5.1B
Q2 24
$3.2B
$5.1B
Q1 24
$2.3B
$5.4B
Net Profit
BEKE
BEKE
THC
THC
Q4 25
$104.9M
$644.0M
Q3 25
$182.4M
$579.0M
Q2 25
$522.0M
Q1 25
$117.9M
$622.0M
Q4 24
$572.0M
Q3 24
$166.5M
$681.0M
Q2 24
$261.5M
$477.0M
Q1 24
$59.8M
$2.3B
Gross Margin
BEKE
BEKE
THC
THC
Q4 25
21.4%
Q3 25
21.9%
Q2 25
Q1 25
20.7%
Q4 24
Q3 24
22.7%
Q2 24
27.9%
Q1 24
25.2%
Operating Margin
BEKE
BEKE
THC
THC
Q4 25
2.6%
15.4%
Q3 25
4.1%
16.8%
Q2 25
15.6%
Q1 25
2.5%
18.1%
Q4 24
16.2%
Q3 24
3.2%
21.3%
Q2 24
8.6%
14.9%
Q1 24
0.1%
61.2%
Net Margin
BEKE
BEKE
THC
THC
Q4 25
3.2%
11.7%
Q3 25
5.0%
10.9%
Q2 25
9.9%
Q1 25
3.7%
11.9%
Q4 24
11.3%
Q3 24
5.2%
13.3%
Q2 24
8.1%
9.3%
Q1 24
2.6%
43.5%
EPS (diluted)
BEKE
BEKE
THC
THC
Q4 25
$4.22
Q3 25
$3.86
Q2 25
$3.14
Q1 25
$4.27
Q4 24
$3.79
Q3 24
$4.89
Q2 24
$2.64
Q1 24
$21.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BEKE
BEKE
THC
THC
Cash + ST InvestmentsLiquidity on hand
$1.3B
$2.9B
Total DebtLower is stronger
$13.1B
Stockholders' EquityBook value
$4.2B
Total Assets
$16.8B
$29.7B
Debt / EquityLower = less leverage
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BEKE
BEKE
THC
THC
Q4 25
$1.3B
$2.9B
Q3 25
$1.6B
$3.0B
Q2 25
$2.6B
Q1 25
$1.8B
$3.0B
Q4 24
$3.0B
Q3 24
$1.4B
$4.1B
Q2 24
$1.3B
$2.9B
Q1 24
$2.5B
$2.5B
Total Debt
BEKE
BEKE
THC
THC
Q4 25
$13.1B
Q3 25
$13.1B
Q2 25
$13.1B
Q1 25
$13.1B
Q4 24
$13.1B
Q3 24
$12.8B
Q2 24
$12.8B
Q1 24
$12.8B
Stockholders' Equity
BEKE
BEKE
THC
THC
Q4 25
$4.2B
Q3 25
$9.6B
$4.0B
Q2 25
$3.7B
Q1 25
$9.5B
$4.2B
Q4 24
$4.2B
Q3 24
$10.1B
$3.8B
Q2 24
$9.7B
$3.5B
Q1 24
$9.6B
$3.5B
Total Assets
BEKE
BEKE
THC
THC
Q4 25
$16.8B
$29.7B
Q3 25
$17.3B
$29.4B
Q2 25
$28.7B
Q1 25
$18.0B
$29.2B
Q4 24
$28.9B
Q3 24
$17.5B
$29.4B
Q2 24
$16.9B
$29.3B
Q1 24
$16.5B
$28.9B
Debt / Equity
BEKE
BEKE
THC
THC
Q4 25
3.10×
Q3 25
3.26×
Q2 25
3.49×
Q1 25
3.13×
Q4 24
3.14×
Q3 24
3.33×
Q2 24
3.67×
Q1 24
3.70×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BEKE
BEKE
THC
THC
Operating Cash FlowLast quarter
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BEKE
BEKE
THC
THC
Q4 25
$731.0M
Q3 25
$1.1B
Q2 25
$936.0M
Q1 25
$-546.4M
$815.0M
Q4 24
$-331.0M
Q3 24
$64.0M
$1.0B
Q2 24
$747.0M
Q1 24
$586.0M
Free Cash Flow
BEKE
BEKE
THC
THC
Q4 25
$367.0M
Q3 25
$778.0M
Q2 25
$743.0M
Q1 25
$642.0M
Q4 24
$-661.0M
Q3 24
$829.0M
Q2 24
$602.0M
Q1 24
$346.0M
FCF Margin
BEKE
BEKE
THC
THC
Q4 25
6.6%
Q3 25
14.7%
Q2 25
14.1%
Q1 25
12.3%
Q4 24
-13.0%
Q3 24
16.2%
Q2 24
11.8%
Q1 24
6.4%
Capex Intensity
BEKE
BEKE
THC
THC
Q4 25
6.6%
Q3 25
5.3%
Q2 25
3.7%
Q1 25
3.3%
Q4 24
6.5%
Q3 24
4.2%
Q2 24
2.8%
Q1 24
4.5%
Cash Conversion
BEKE
BEKE
THC
THC
Q4 25
1.14×
Q3 25
1.83×
Q2 25
1.79×
Q1 25
-4.64×
1.31×
Q4 24
-0.58×
Q3 24
0.38×
1.53×
Q2 24
1.57×
Q1 24
0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BEKE
BEKE

New home transaction services$932.6M29%
Existing home transaction services$841.5M26%
Home rental services$804.4M25%
Home renovation and furnishing$604.0M19%
Emerging and other services$55.6M2%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons